1. Home
  2. PCRX vs OSPN Comparison

PCRX vs OSPN Comparison

Compare PCRX & OSPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PCRX
  • OSPN
  • Stock Information
  • Founded
  • PCRX 2006
  • OSPN 1991
  • Country
  • PCRX United States
  • OSPN United States
  • Employees
  • PCRX N/A
  • OSPN N/A
  • Industry
  • PCRX Biotechnology: Pharmaceutical Preparations
  • OSPN EDP Services
  • Sector
  • PCRX Health Care
  • OSPN Technology
  • Exchange
  • PCRX Nasdaq
  • OSPN Nasdaq
  • Market Cap
  • PCRX 1.2B
  • OSPN 702.8M
  • IPO Year
  • PCRX 2011
  • OSPN 1998
  • Fundamental
  • Price
  • PCRX $26.59
  • OSPN $18.98
  • Analyst Decision
  • PCRX Buy
  • OSPN Strong Buy
  • Analyst Count
  • PCRX 10
  • OSPN 5
  • Target Price
  • PCRX $29.30
  • OSPN $16.50
  • AVG Volume (30 Days)
  • PCRX 892.8K
  • OSPN 379.8K
  • Earning Date
  • PCRX 02-27-2025
  • OSPN 02-27-2025
  • Dividend Yield
  • PCRX N/A
  • OSPN 0.64%
  • EPS Growth
  • PCRX N/A
  • OSPN N/A
  • EPS
  • PCRX N/A
  • OSPN 0.75
  • Revenue
  • PCRX $694,957,000.00
  • OSPN $244,936,000.00
  • Revenue This Year
  • PCRX $5.14
  • OSPN $4.28
  • Revenue Next Year
  • PCRX $2.44
  • OSPN $3.43
  • P/E Ratio
  • PCRX N/A
  • OSPN $24.63
  • Revenue Growth
  • PCRX 4.40
  • OSPN 7.05
  • 52 Week Low
  • PCRX $11.16
  • OSPN $9.22
  • 52 Week High
  • PCRX $31.67
  • OSPN $20.16
  • Technical
  • Relative Strength Index (RSI)
  • PCRX 77.75
  • OSPN 45.16
  • Support Level
  • PCRX $25.06
  • OSPN $18.27
  • Resistance Level
  • PCRX $27.10
  • OSPN $20.16
  • Average True Range (ATR)
  • PCRX 1.45
  • OSPN 0.70
  • MACD
  • PCRX 0.28
  • OSPN -0.06
  • Stochastic Oscillator
  • PCRX 86.23
  • OSPN 4.76

About PCRX Pacira BioSciences Inc.

Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company has three commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve.

About OSPN OneSpan Inc.

OneSpan Inc is a provider of information technology security solutions for banking and financial services and application security markets. Its solutions secure and manage access to digital assets and protect online transactions, via mobile devices and in-person. Authentication and anti-fraud solutions are the organization's primary product offerings and include multifactor authentication and virtual private network access capabilities. The company derives revenues from hardware and license fees, maintenance and support fees, and subscription fees. A large majority of the firm's revenue is generated in Europe, the Middle East, and Africa, and the rest in the United States and Asia-Pacific region.

Share on Social Networks: